AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Clinical trial NCT06063850 · RECRUITING
Trial details
- NCT number
- NCT06063850
- Sponsor
- UniQure Biopharma B.V.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2026-11-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.